OSX — Osteopore Income Statement
0.000.00%
Last trade - 00:00- AU$1.99m
- AU$2.68m
- AU$2.76m
Annual income statement for Osteopore, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.5 | 1.11 | 1.69 | 2.22 | 2.76 |
| Cost of Revenue | |||||
| Gross Profit | 0.955 | 0.812 | 1.27 | 1.64 | 2.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.43 | 4.72 | 5.87 | 7.03 | 5.71 |
| Operating Profit | -1.93 | -3.6 | -4.17 | -4.81 | -2.94 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.95 | -3.62 | -4.2 | -4.83 | -3.33 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.95 | -3.62 | -4.2 | -4.87 | -3.35 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.95 | -3.62 | -4.2 | -4.87 | -3.35 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.95 | -3.62 | -4.2 | -4.87 | -3.35 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.048 | -0.082 | -0.09 | -0.091 | -0.043 |